Uwell Biopharma Market Cap

Uwell Biopharma has a market cap or net worth of 8.95 billion as of March 2, 2026.

Market Cap

8.95B

Enterprise Value

8.73B

Revenue

450.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

46.00

Market Cap Chart

Since January 22, 2026, Uwell Biopharma's market cap has increased from 5.52B to 8.95B, an increase of 62.14%. That is a compound annual growth rate of 9,110.83%.

Market Cap History

Date	Market Cap	% Change
Mar 2, 2026	8.95B	-2.72%
Feb 26, 2026	9.20B	-7.91%
Feb 25, 2026	9.99B	-1.09%
Feb 24, 2026	10.10B	15.96%
Feb 23, 2026	8.71B	29.23%
Feb 11, 2026	6.74B	0.60%
Feb 10, 2026	6.70B	0.45%
Feb 9, 2026	6.67B	-0.74%
Feb 6, 2026	6.72B	-2.61%
Feb 5, 2026	6.90B	2.37%
Feb 4, 2026	6.74B	2.43%
Feb 3, 2026	6.58B	5.11%
Feb 2, 2026	6.26B	12.79%
Jan 30, 2026	5.55B	2.78%
Jan 29, 2026	5.40B	1.89%
Jan 28, 2026	5.30B	-3.46%
Jan 27, 2026	5.49B	9.15%
Jan 26, 2026	5.03B	-0.79%
Jan 23, 2026	5.07B	-8.15%
Jan 22, 2026	5.52B	-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genesys Logic	9.25B
Gamania Digital Entertainment	9.25B
Netronix	9.21B
Forcecon Technology	9.13B
Lanner Electronics	9.05B
Hsin Tai Gas	8.96B
P-Duke Technology	8.96B
QST International	8.91B

Market Cap Rankings